HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bust Booster Niacin Effect Supported By Subjective Measure, Firm Tells NAD

This article was originally published in The Rose Sheet

Executive Summary

Basic Research plans to appeal some conclusions of the National Advertising Division of the Council of Better Business Bureaus before discontinuing print and Internet advertising claims that its Bust Booster Breast Enhancement product increases breast size

You may also be interested in...



Evidence Lacking For Bosom Max Claims; ERSP Advises Discontinuation

Claims for breast enhancement system Bosom Max are not properly substantiated, according to the Electronic Retailing Self-Regulation Program, which is reporting the advertiser to regulatory authorities.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
UsernamePublicRestriction

Register

RS011004

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel